Abstract 16349: A Novel Class of Inhibitors That Are Specific to Human NPP1 Prevent Pathologic Mineralization of Valve Interstitial Cells
Elnur Elyar Shayhidin(Université Laval), Patrick Mathieu(Institut universitaire de cardiologie et de pneumologie de Québec), Elsa Forcellini(Université Laval), Ablajan Mahmut(Valve (United States)), Xavier Barbeau(PROTEO), Sébastien Dautrey(Université Laval), Marie‐Chloé Boulanger(Institut universitaire de cardiologie et de pneumologie de Québec), Patrick Lagüe(PROTEO), Jean‐François Paquin(Université Laval), Jean Sévigny(Université Laval)
Cited by 0
Related Papers
The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance
|Purinergic Signalling|2006|928
Identification and Characterization of CD39/Vascular ATP Diphosphohydrolase
|Journal of Biological Chemistry|1996|586
Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation
|Nature Medicine|1999|575
Carbon Monoxide Generated by Heme Oxygenase-1 Suppresses the Rejection of Mouse-to-Rat Cardiac Transplants
|The Journal of Immunology|2001|462
A Proteomic Analysis of Arginine-methylated Protein Complexes
|Molecular & Cellular Proteomics|2003|358